Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin to prevent frailty in pre-frail elderly
NCT02325245Phase 3Unknown
- Sponsor
- Universitas Indonesia
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of liquid metformin (Aspargo Labs) in frailty syndrome, sponsored by Universitas Indonesia. Primary endpoint: Change from baseline in frailty status at 16 weeks. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
frailty syndrome
Beyond the preview
Go deeper on NCT02325245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325245.